Saudi Arabia leads globally in water safety standards as drowning deaths drop 17%
RIYADH — Saudi Arabia has achieved global leadership in water safety and drowning prevention standards, following the adoption of its National Drowning Prevention Policy, the Ministry of Environment, Water and Agriculture announced.
The ministry revealed a 17% decrease in drowning fatalities, attributing the progress to the effectiveness of nationwide safety programs and their social and economic impact.
The announcement came during a workshop held to mark World Drowning Prevention Day, observed annually on July 25.
Launched in collaboration with the Public Health Authority (Weqaya) and various government bodies, the ministry has activated the awareness campaign through internal programs and its digital platforms to promote safe behavior around water and strengthen public understanding of preventive measures.
According to the workshop, the Kingdom's leading position was achieved through the implementation of 12 integrated national initiatives aimed at drowning prevention.These efforts have helped Saudi Arabia avoid an estimated economic burden exceeding SR800 million—highlighting the tangible impact of its proactive safety policies.The National Drowning Prevention Policy seeks to enhance water safety through a unified national framework that protects lives across the Kingdom's various aquatic environments.The policy is rooted in domestic regulations and aligned with international conventions, applying best global practices tailored to Saudi Arabia's unique environmental and geographic context.Officials emphasized that the sharp reduction in drowning incidents and avoided economic costs are the result of cohesive national action and inter-agency cooperation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Saudi Gazette
17 hours ago
- Saudi Gazette
SFDA shuts frozen food factory, halts production lines over serious violations
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has shut down a frozen ready-to-eat food factory and suspended production lines at several other facilities after uncovering serious health violations that posed direct risks to consumer safety. The enforcement actions followed inspection campaigns carried out last month as part of SFDA's proactive monitoring program to ensure compliance with national food safety standards and prevent potential foodborne illnesses. In one facility producing pickles and ready meals, inspectors found poor hygiene, unsafe operating practices, and ineffective safety supervision — conditions conducive to the growth of harmful pathogens such as Listeria monocytogenes, E. coli, and Salmonella spp., all of which can cause acute food poisoning. Although the facility was given a deadline to correct the violations under Article 12 of the Food Law (Royal Decree No. M/38, dated 28/4/1440H), it failed to comply within the required timeframe. This led to the full suspension of its production lines and the initiation of legal proceedings. In a separate case, violations were detected at another facility producing ready-to-eat poultry products. These included employing unlicensed workers, lacking a valid HACCP food safety certification, storing expired food without clear separation, and using corroded, unsafe food-contact equipment. The SFDA imposed fines under Article 20 of the Food Law's executive regulations and partially suspended the facility's operations until corrective measures are taken. Additionally, the authority suspended 11 production lines across several dairy and frozen pastry plants after lab tests confirmed contamination with Clostridium perfringens, a common cause of foodborne illness. All facilities were instructed to implement corrective action plans within 30 days, including upgrading quality systems, retraining staff, and replacing non-compliant equipment. Follow-up inspections will ensure compliance. The SFDA emphasized that these actions reflect its commitment to preventive public health protection and are supported by legal provisions allowing stringent measures, including suspension, imprisonment, or fines up to SR10 million. The authority urged consumers to report any suspected food violations via the unified hotline (19999), affirming that food safety is a shared responsibility from production to the dining table.
Saudi Gazette
2 days ago
- Saudi Gazette
Saudi Arabia approves first Alzheimer's treatment with lecanemab for early-stage patients
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has officially approved the registration of lecanemab (Leqembi) for the treatment of patients with early-stage Alzheimer's disease, specifically those with mild cognitive impairment or mild dementia, who carry no copies or just one copy of the ApoE4 gene variant. This marks the first approved Alzheimer's treatment in the Kingdom. In a statement, the SFDA noted that lecanemab is a biologic drug based on monoclonal antibody technology, and is the first biologic therapy licensed for Alzheimer's in Saudi Arabia. The treatment works by targeting amyloid beta protein plaques in the brain, a hallmark of Alzheimer's pathology, thereby helping slow cognitive decline. The drug is administered via intravenous infusion every two weeks. The authority said the approval followed a comprehensive evaluation of the drug's efficacy, safety, and quality, with clinical trials showing that lecanemab slows the progression of symptoms compared to placebo, based on established Alzheimer's disease assessment scales. The most commonly reported side effects included headaches, infusion-related reactions, and amyloid-related imaging abnormalities (ARIA) — brain changes detectable via MRI that may involve brain swelling or microbleeds. The SFDA emphasized the importance of ongoing patient monitoring during treatment, particularly for any emerging side effects. Genetic testing is required before initiating therapy to assess patient eligibility and reduce risk of adverse reactions. The authority also required the manufacturer to submit regular post-marketing reports on the drug's effectiveness and safety, and to implement a risk management plan to ensure the treatment's optimal and safe use.
Saudi Gazette
2 days ago
- Saudi Gazette
Jamaican conjoined twins arrive in Riyadh for possible separation surgery
Saudi Gazette report RIYADH — The conjoined Jamaican twins, Azaria and Azura Elison, arrived Monday at King Khalid International Airport in Riyadh aboard a medical evacuation flight operated by the Saudi Ministry of Defense. Upon arrival, the twins were transferred to King Abdullah Specialist Children's Hospital at King Abdulaziz Medical City under the Ministry of National Guard for a comprehensive medical evaluation and to assess the feasibility of a separation surgery. The initiative comes in line with the directives of Custodian of the Two Holy Mosques King Salman bin Abdulaziz and Crown Prince and Prime Minister Mohammed bin Salman, reflecting Saudi Arabia's ongoing humanitarian commitment to complex pediatric cases around the world. Dr. Abdullah Al Rabeeah, Supervisor General of the King Salman Humanitarian Aid and Relief Center and head of the medical and surgical team for the Saudi Conjoined Twins Program, expressed deep gratitude to the Saudi leadership. He praised the Kingdom's advanced medical capabilities and humanitarian leadership in treating children with complex conditions noted that the Saudi medical team has built significant expertise over the years, having successfully performed numerous separation surgeries, making Saudi Arabia a global reference in this highly specialized twins' family expressed heartfelt appreciation to the Kingdom's leadership and people for their warm reception, generous hospitality, and swift response to the twins' condition.
